A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD.
Epistemonikos ID: b51ccfe845ed82ca58b7f4feb17092a6cd01ed99
First added on: Feb 01, 2025